Two Sigma Investments, LP Opti Nose, Inc. Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.43 - $4.01 $131,369 - $153,583	38,300 New	38,300 $140,000
Q2 2020 Aug 14, 2020	SELL	$3.58 - $7.44 $73,504 - $152,758	-20,532 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.49 - $9.2 $33,570 - $88,494	-9,619 Reduced 31.9%	20,532 $92,000
Q4 2019 Feb 14, 2020	BUY	$6.27 - $11.41 $189,046 - $344,022	30,151 New	30,151 $278,000
Q1 2019 May 15, 2019	SELL	$6.1 - $10.3 $635,522 - $1.07 Million	-104,184 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$5.84 - $11.92 $608,434 - $1.24 Million	104,184 New	104,184 $646,000
Q3 2018 Nov 14, 2018	SELL	$12.43 - $29.76 $408,947 - $979,104	-32,900 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$18.75 - $28.46 $616,875 - $936,334	32,900 New	32,900 $921,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $31.6M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.